「Prognostic value of somatic mutations at remission in acute myeloid leukemia」の関連論文
-
A multicenter, open‑label, single‑arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
-
超低頻度な体細胞点突然変異定量法の新規開発とがん化学療法による正常血液細胞への変異蓄積の証明
-
Study on the clinical outcome and molecular changes of precursor-targeted immune-mediated anemia treated with splenectomy [an abstract of entire text]
-
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
-
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas
-
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
-
ロングリードシークエンサーを用いた神経核内封入体病の分子病態解明
-
The roles of adipose-tissue and malignant ascites in the development of peritoneal metastasis and the progression of ovarian cancer
-
日本人高度蛋白尿患者に対する包括的遺伝子診断
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
卵巣癌におけるクロマチンリモデリング 因子CHD4の機能に関する研究
-
Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
-
The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis
-
皮膚原発神経内分泌腫瘍におけるRB1遺伝子のターゲットシーケンスを含む臨床病理学的検討
-
Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer
-
膵癌における新規S-1感受性予測因子のプロテオミクスによる網羅的探索
-
免疫チェックポイント阻害薬使用患者の癌種横断的レジストリの構築、ならびに治療効果・免疫関連有害事象発現の予測に関する研究
-
胃癌におけるSWI/SNF複合体異常及び免疫回避機構関連因子の検討
-
悪性リンパ腫における血中循環細胞外遊離DNAを用いたゲノム解析に関する研究
-
Newly established patient-derived organoid model of intracranial meningioma
-
Analysis of genetic risk factors in Japanese patients with Parkinson’s disease
-
Analysis of genetic risk factors in Japanese patients with Parkinson’s disease
-
視床高悪性度神経膠腫摘出例におけるヒストン変異およびTERT promoter変異と生存予後に関する研究
-
Prognostic role of the innate immune signature CD163 and
-
Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
-
慢性気道感染症のエリスロマイシン療法における遺伝子および遺伝子制御マーカーの研究
-
Prognostic role of the innate immune signature CD163 and
-
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
-
Identification of the new gene causing cerebellar ataxia and investigation of pathogenic mechanism
-
シングルセルトランスクリプトーム解析を用いた食道扁平上皮癌内の腫瘍浸潤Bリンパ球における化学療法後の機能変化の解明
-
KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma
-
TP53遺伝子変異がp53経路の遺伝子発現に及ぼす影響に関するがん種横断的研究
-
SMAD4発現保持とRUNX3発現喪失は膵管癌予後不良因子となる
-
The incidence of malignancy, complications, and the prognosis after direct-acting antiviral therapy for chronic hepatitis C
-
How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma?
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
-
全エクソーム解析による成人発症遺伝性ミオパチーの新規遺伝子変異同定
-
Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients
-
癌性腹膜炎を伴う進行卵巣癌に対する新規治療戦略
-
A novel patient-derived pancreatic acinar cell carcinoma cell line shows high sensitivity to bortezomib
-
A Clinicopathological Study of Metachronous Anaplastic Carcinoma Transformed from Recurrent Papillary Thyroid Carcinoma
-
非小細胞肺癌におけるインテグリンα11の発現と術後再発に関する解析
-
マルファン症候群の大動脈におけるマクロファージの関与、および遺伝子型と臨床像の解析
-
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
-
骨軟部肉腫の薬剤感受性に関与するlong non-coding RNAの研究
-
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
-
<学会抄録>第70回日本泌尿器科学会中部総会
-
同時性多発大腸癌の臨床病理・分子学的解析
-
末梢血免疫担当細胞トランスクリプトーム解析による混合性結合組織病に伴う間質性肺炎の病態機序の解明